Receptor, the use thereof, and mouse antibodies
CA 2455154 A1 · Owner: Oncomab Gmbh · Inventors: Vollmers, Heinz; Mueller-Hermelink, Hans Konrad; Hensel, Frank
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a receptor located on the surface membrane of highly proliferative cells, particularly of the gastric carcinoma which is composed , of glycoproteins. At least one determinant of the glycoprotein corresponds with one of the CFR-1 protein, and the human antibody 103/51 and/or the murine antibody 58/47-69 (lgM) specifically binds to the glycoprotein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.